News

Filter

Current filters:

StallergenesResearch

Stallergenes publishes review of grass pollen tablet confirming efficacy

Stallergenes publishes review of grass pollen tablet confirming efficacy

24-06-2014

French allergen specialist Stallergenes has released comprehensive new data on the 5-grass pollen immunotherapy…

FrancePharmaceuticalResearchRespiratory and PulmonaryStallergenes

Stallergenes links with ActoGeniX on new class of oral allergy treatments

03-12-2013

French allergen specialist Stallergenes and ActoGeniX NV, creator of ActoBiotics, have entered into an…

ActoBioticsActoGeniXImmunologicalsLicensingPharmaceuticalResearchStallergenes

Stallergenes and DBV Technologies collaborate in birch pollen allergy research

18-10-2013

French allergy specialists Stallergenes and DBV Technologies, creator of Viaskin for the treatment of…

DBV TechnologiesImmunologicalsPharmaceuticalResearchRespiratory and PulmonaryStallergenes

Stallergenes and DBV Technologies partner on developing novel respiratory allergies treatments

20-05-2013

French biotech firms DBV Technologies (Euronext: DBV), creator of Viaskin, a new standard in the treatment…

BiotechnologyDBV TechnologiesLicensingResearchRespiratory and PulmonaryStallergenes

Back to top